HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Armando Bartolazzi Selected Research

Galectin 3 (LGALS3)

1/2021Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (89Zr)-DFO- Galectin3-F(ab')2 mAb.
1/2020Development of a Chimeric Antigen-Binding Fragment Directed Against Human Galectin-3 and Validation as an Immuno-Positron Emission Tomography Tracer for the Sensitive In Vivo Imaging of Thyroid Cancer.
3/2019Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs.
1/2019Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer.
2/2018Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.
1/2018Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice.
10/2016Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules.
1/2016Noninvasive In Vivo Imaging and Biologic Characterization of Thyroid Tumors by ImmunoPET Targeting of Galectin-3.
1/2012Methodology and technical requirements of the galectin-3 test for the preoperative characterization of thyroid nodules.
1/2012Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Armando Bartolazzi Research Topics

Disease

29Neoplasms (Cancer)
10/2021 - 01/2004
9Thyroid Neoplasms (Thyroid Cancer)
04/2021 - 01/2008
9Thyroid Nodule (Nodule, Thyroid)
02/2018 - 02/2003
7Melanoma (Melanoma, Malignant)
01/2019 - 01/2002
3Neuroblastoma
01/2018 - 01/2011
3Uveal melanoma
11/2008 - 01/2002
2Papillary Carcinoma
11/2016 - 04/2005
2Neoplasm Metastasis (Metastasis)
01/2012 - 01/2002
1Disease Progression
06/2021
1Eosinophilia
06/2021
1Atherosclerotic Plaque (Atheroma)
01/2021
1Genomic Instability
01/2021
1Atherosclerosis
01/2021
1Kimura Disease
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
11/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2019
1Skin Diseases (Skin Disease)
01/2019
1Vitamin D Deficiency
01/2019
1Lung Neoplasms (Lung Cancer)
12/2018
1Sarcoma (Soft Tissue Sarcoma)
11/2018
1Bone Resorption
01/2018
1Experimental Melanoma
11/2017
1Breast Neoplasms (Breast Cancer)
08/2015
1Ovarian Neoplasms (Ovarian Cancer)
04/2014
1Fibrosis (Cirrhosis)
01/2013
1Idiopathic Pulmonary Fibrosis
01/2013
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011

Drug/Important Bio-Agent (IBA)

19Galectin 3 (LGALS3)IBA
01/2021 - 02/2003
8Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2002
4Galectins (Galectin)IBA
03/2019 - 06/2006
4Biological ProductsIBA
02/2018 - 01/2012
3Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2012
3Insulin-Like Growth Factor I (IGF-1)IBA
11/2008 - 01/2002
3ParaffinIBA
11/2008 - 01/2002
2AntigensIBA
01/2020 - 04/2014
2Vitamin DFDA LinkGeneric
01/2019 - 11/2017
2Carrier Proteins (Binding Protein)IBA
01/2016 - 01/2012
2Tumor Biomarkers (Tumor Markers)IBA
04/2014 - 01/2012
2nutlin 3IBA
01/2012 - 01/2011
2AntibodiesIBA
11/2008 - 12/2005
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2008 - 12/2005
2Insulin (Novolin)FDA Link
01/2004 - 01/2002
1MK-8776IBA
10/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2021
1olaparibIBA
10/2021
1Immunoglobulin G (IgG)IBA
06/2021
1Immunoglobulin E (IgE)IBA
06/2021
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
04/2021
1IodineIBA
04/2021
1RNA (Ribonucleic Acid)IBA
03/2021
1Retroelements (Retrotransposon)IBA
03/2021
1DNA (Deoxyribonucleic Acid)IBA
03/2021
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2021
1Apolipoproteins E (ApoE)IBA
01/2021
1ApolipoproteinsIBA
01/2021
1Cyclin DIBA
01/2021
1Retinoblastoma ProteinIBA
01/2021
1Amino AcidsFDA Link
01/2020
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2020
1Mitogen-Activated Protein Kinase 13IBA
11/2019
1p38 Mitogen-Activated Protein KinasesIBA
11/2019
1pembrolizumabIBA
03/2019
1B7-H1 AntigenIBA
03/2019
1sodium-iodide symporter (sodium iodide symporter)IBA
01/2019
125-hydroxyvitamin DIBA
01/2019
1BromidesIBA
01/2019
1hydroxide ionIBA
01/2019
1MF 438IBA
12/2018
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2018
1Stearoyl-CoA DesaturaseIBA
12/2018
1GemcitabineFDA Link
11/2018
1CateninsIBA
01/2018
1Tartrate-Resistant Acid PhosphataseIBA
01/2018
16- (4- hydroxyphenyl)- 2- thioxo- 2,3- dihydro- 4(1H)- pyrimidinoneIBA
01/2018
1Alkaline PhosphataseIBA
01/2018
1MicroRNAs (MicroRNA)IBA
01/2018
1Calcifediol (Calcidiol)FDA Link
11/2017
1HydroxycholecalciferolsIBA
11/2017
1Capsules (Microcapsules)IBA
11/2016
1Uridine Monophosphate (UMP)IBA
10/2016
1MetalsIBA
08/2015
1Progesterone Receptors (Progesterone Receptor)IBA
08/2015
1cytolethal distending toxinIBA
08/2015
1Estrogens (Estrogen)FDA Link
08/2015
1Volatile Organic CompoundsIBA
08/2015
1OxidesIBA
08/2015
1Phosphotransferases (Kinase)IBA
04/2015
1S100 Proteins (S 100 Protein)IBA
06/2014
1Keratins (Keratin)IBA
06/2014
1Cancer VaccinesIBA
04/2014
1AcitretinFDA Link
09/2011
1A-Form DNA (A-DNA)IBA
01/2011

Therapy/Procedure

9Therapeutics
10/2021 - 07/2002
2Drug Therapy (Chemotherapy)
10/2021 - 04/2014
2Surgical Amputation (Amputations)
11/2018 - 03/2009
2Thyroidectomy
10/2016 - 06/2008
2Combined Modality Therapy
01/2012 - 01/2011
1Intravenous Injections
01/2020
1Immunotherapy
03/2019
1Semiconductors
08/2015